Tolulope Adeyemo
Family Medicine · Smyrna, GANPI 1841588068
Payments from drug & device makers
Across 109 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$352
- Astellas Pharma US Inc$245
- AstraZeneca$157
- Johnson & Johnson$142
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$117
- GSK$115
- plus $842 from 26 others
What the payments were for
- Food & beverage$1,971100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $352 |
| Astellas Pharma US Inc | 12 | $245 |
| AstraZeneca | 11 | $157 |
| Johnson & Johnson | 5 | $142 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $117 |
| GSK | 7 | $115 |
| Lilly USA, LLC | 7 | $107 |
| Sanofi-aventis U.S. LLC | 4 | $74 |
| AbbVie(2 entities) | 3 | $67 |
| Dynavax Technologies Corporation | 2 | $50 |
| Merck | 3 | $48 |
| Abbott | 2 | $44 |
| Gilead | 2 | $38 |
| Boehringer Ingelheim | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Coloplast | 1 | $29 |
| Bayer | 2 | $29 |
| Genentech USA, Inc. | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Shield Therapeutics Inc | 1 | $23 |
| Phadia US Inc. | 1 | $18 |
| Amgen | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Dermira, Inc. | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Nalpropion Pharmaceuticals LLC | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Pfizer | 1 | $12 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Adlon Therapeutics L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVOKANA$125
How this compares
$1,971 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 61 | $90,449 |
| OzempicSemaglutide | 46 | $69,819 |
| FarxigaDapagliflozin Propanediol | 45 | $57,356 |
| RybelsusSemaglutide | 28 | $52,913 |
| Spiriva RespimatTiotropium Bromide | 41 | $35,139 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $30,157 |
| XareltoRivaroxaban | 21 | $28,284 |
| JanuviaSitagliptin Phosphate | 25 | $26,902 |
| MyrbetriqMirabegron | 21 | $22,624 |
| JardianceEmpagliflozin | 12 | $19,056 |
| Incruse ElliptaUmeclidinium Bromide | 37 | $17,175 |
| EntrestoSacubitril/Valsartan | 15 | $15,518 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 102 | $15,441 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $14,169 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 316 | $14,071 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $352 | $122,73274 claims |
| PfizerEliquis | $12 | $90,44961 claims |
| AstraZenecaFarxiga, Symbicort | $157 | $71,52576 claims |
| Boehringer IngelheimSpiriva Respimat, Jardiance | $37 | $54,19553 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $115 | $47,33373 claims |
| Johnson & JohnsonXarelto | $142 | $28,28421 claims |
| MerckJanuvia | $48 | $26,90225 claims |
| Astellas Pharma US IncMyrbetriq | $245 | $22,62421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Smyrna
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.